{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-018048","form_type":"8-K","ticker":"CVSI","cik":"0001510964","company_name":"CV Sciences, Inc.","filed_at":"2025-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.841532+00:00","generated_at":"2026-05-26T23:20:08.739993+00:00","sec_items":["1.02","1.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CV Sciences disputes Extract Labs acquisition termination by Sellers; evaluating options","bullets":["On Feb 5, 2025, Extract Labs owners informed CV Sciences they cannot close due to alleged failure to obtain bank consent, purportedly terminating the Stock Purchase Agreement.","CV Sciences disputes the Sellers' right to terminate and reserves all rights; evaluating legal options.","The Purchase Agreement was entered on Nov 21, 2024, for CV Sciences to acquire all outstanding shares of Extract Labs."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-018048","json":"https://secwatch.observer/filing/0000950170-25-018048.json","markdown":"https://secwatch.observer/filing/0000950170-25-018048.md","text":"https://secwatch.observer/filing/0000950170-25-018048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1510964/000095017025018048/0000950170-25-018048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1510964/000095017025018048/cvsi-20250205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:20:08.739993+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}